Participated · Seed · Feb 2026

Boomband is building a human-first hiring platform that centers on 360-degree “Dossiers” for job seekers and AI-generated “Job Signals” for employers, eliminating traditional resumes and cold applications. Its real-time discovery engine, the Arena, matches “Players” (candidates) and “Scouts” (companies) based on mutual alignment rather than keyword filters. Founded by Monster.com creator Jeff Taylor, the company aims to solve industry pain points like applicant overload and candidate ghosting. Boomband will launch publicly in March 2026, beginning in New England with early corporate partners such as UWill, Leader Bank, CRH, Zus Health, Rochester Electronics, and South Shore Health. The platform targets sectors including tech, healthcare, financial services, and manufacturing. Backed by $4.0 million in seed funding, Boomband plans to expand nationwide later in 2026. The company is currently enrolling early adopters on its website.

Participated · Series A · Nov 2025

Joy is a San Francisco-based company developing an advanced artificial-intelligence platform tailored to the needs of parents. Through its flagship offering, the Joy Parenting Club, members receive round-the-clock access to certified parenting professionals, including parent coaches and lactation consultants. The platform aims to improve every stage of the parenting journey by combining expert human guidance with AI-driven personalization. Looking ahead, Joy plans to deepen integrations with leading baby and parenting brands to create a more seamless ecosystem for families. The company also intends to expand its network of specialists so it can cover a wider range of childhood topics and developmental milestones. Newly secured capital will further accelerate product development, broaden service coverage, and enhance the underlying AI technology that powers user experiences.

Participated · Series A · Aug 2024

Founded in 2020 by Harvard Business School classmates Tina Keshani, Julia Cole, and Sophia Richter, Seven Starling delivers technology-enabled maternal mental-health care. Its platform combines clinical evaluations, medication management, and both individual and group therapy to treat depression, anxiety, and related conditions tied to parenthood. All services are covered by insurance, helping patients access support without prohibitive out-of-pocket costs. The company plans to use new capital to expand into a dozen additional states by the end of 2026. Seven Starling’s care model targets postpartum, infertility, miscarriage, and loss, aiming to close gaps in traditional maternal health services. To date, the startup has raised $21.8 million across three rounds, giving it resources to scale its virtual operations and provider network.

Participated · Seed · May 2024

Light Frame is developing a proprietary technology platform designed to deliver enhanced levels of autonomy, capability, and intelligence within the operations of private banks and wealth management firms. The company intends to use its recent funding to accelerate product innovation and growth. Light Frame opened its American headquarters at the Cambridge Innovation Center in downtown Providence in early 2024 and also maintains an office in Lausanne, Switzerland. The team includes technologists and former banking executives focused on bringing advanced operational automation to the sector. The company was founded in January 2024 and is positioning itself as a technology partner for private banks and wealth managers.

Led · Equity · Jan 2024

InVivo Biosystems provides CRISPR genome editing and end-to-end preclinical services, creating custom genome-edited C. elegans and zebrafish models and delivering in-vivo analytical data to support early-stage drug development. The company leverages extensive intellectual property in genetically modified organisms to accelerate target identification and compound screening with rapid turnaround and affordability. In January 2024 it announced a $3M new investment to advance commercialization of its CRISPR capabilities. Recent technology validation includes new patents, an exclusive license (MIC-Drop) from the University of Utah for a high-throughput CRISPR microfluidic approach, and an NIH Fast-Track SBIR award. The NIH grant — $2.8M — will fund development of an AI-based automated zebrafish monitoring system to enable automated deep phenotyping. The appointment of C. Palani Palaniappan, Ph.D., as board chairman was announced alongside the financing to support commercialization and corporate strategy in 2024.